Heart News and Research

RSS

Replacement PFAS chemical still harms developing zebrafish embryos

Publishing in the Journal of Hazardous Materials Advances, researchers from Kyushu University used zebrafish embryos to study the health effects of the PFAS called PFBS (Perfluorobutanesulfonic acid), a substitute PFAS thought to be safer than traditional compounds.

11 Nov 2026

Case report highlights urgent communication gaps for deaf NHS patients

Deaf patients get a raw deal in NHS hospitals, suggests an illustrative case history of a deaf person's experience as an inpatient, published in the online journal BMJ Case Reports.

11 Nov 2026

New study links senior living arrangements to mental health outcomes

As traditional multigenerational households have become less common, increasing numbers of older adults are living alone or with only their spouses.

11 Nov 2026

Breakthrough RNA blood test identifies hidden ovarian cancer warning signs

Hoag researchers announced a first in the world discovery of a molecular warning signal in the blood that identifies serous tubal intraepithelial carcinoma (STIC), an early, precancerous stage of high-grade serous ovarian cancer (HGSOC).

11 Nov 2026

Lab Matters host Harriet Gould on building a more connected lab community

Lab Matters host Harriet Gould discusses collaboration, automation, skills, wellbeing and keeping humanity at the heart of laboratory science.

From Lab Innovations 11 Nov 2026

Can psychedelics help treat cancer beyond easing end-of-life fear?

A new peer-reviewed review in Psychedelics opens on a strange fact, gathered from existing laboratory studies rather than new experiments: a brain tumor can learn to eavesdrop.

11 Nov 2026

Omega-3 supplements show surprising effects on blood pressure

Findings suggest omega-3 supplements improve blood pressure and inflammatory biomarkers in hypertensive patients, indicating potential therapeutic benefits.

11 Nov 2026

UCLA introduces single-port robotic approach for lung cancer surgery

UCLA Health performs its first single-port robotic lobectomy, using a new technique that could reduce pain and make recovery easier for patients with lung cancer.

10 Nov 2026

Choir singing improves lung function and mental wellbeing in children

Singing in a choir strengthens breathing capacity, decreases depression and anxiety, and improves perceived school functioning in children born with a single heart ventricle, according to a feasibility study from Ann & Robert H. Lurie Children's Hospital of Chicago published in Pediatric Cardiology.

10 Nov 2026

UTHealth Houston unveils state-of-the-art mobile clinic in the Lower Rio Grande Valley

UTHealth Houston celebrated a major milestone in community healthcare Oct. 22 with the ribbon-cutting ceremony for its new, state-of-the-art mobile clinic in the Lower Rio Grande Valley.

10 Nov 2026

Artery scans detect “silent atherosclerosis” in 1 in 13 adults under 30

Researchers studying 16,808 adults aged 18 to 70 found that silent atherosclerosis was detectable in early adulthood, with plaque present in 57.1% of those who completed imaging across three arterial territories. Plaque prevalence and burden were higher in older age groups, with men showing earlier evidence of disease than women, while conventional cardiovascular risk scores identified relatively few people with existing plaque.

10 Nov 2026

New patient-centered initiative aims to accelerate pediatric AML research and treatments

Blood Cancer United today announced the launch of Dare to Dream REALworld: AML, a patient-centered initiative co-founded with Rally Foundation for Childhood Cancer Research.

10 Nov 2026

Meeting WHO's air pollution guidelines could save nine million lives

Meeting the World Health Organization's recommended annual guidelines for air pollution resulting from fine particulate matter and nitrogen dioxide has the potential to save more than 9 million lives a year in low- and middle-income countries, say University of Cambridge researchers.

10 Nov 2026

Could Ozempic and Wegovy affect unborn babies?

They’re the blockbuster drugs transforming weight loss, helping millions of people to shed unwanted pounds.

10 Nov 2026

Qureight’s fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, and Contineum Therapeutics, Inc. (Contineum), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that Qureight’s Fibr8™ quantitative imaging biomarker is being used as a secondary endpoint in Contineum’s PROPEL-IPF Phase 2 clinical trial examining the safety and efficacy of PIPE-791, Contineum’s lead drug candidate, in idiopathic pulmonary fibrosis (IPF) patients.

10 Nov 2026

Drinking 2–3 cups of coffee a day? A study of 495,000 adults links it to lower AF risk

In a prospective study of 495,269 UK Biobank participants followed for approximately 13 years, researchers found that coffee consumption was associated with a 7% to 11% lower risk of atrial fibrillation (AF), with the strongest association observed at 2–3 cups daily. Tea consumption showed a more modest and less consistent association, with the authors reporting a 5% lower AF risk at 2–3 cups daily, although the observational findings cannot establish causation.

9 Nov 2026

Late night eating and sleep habits damage gut health, increase metabolic disease risk

A new study led by UTHealth Houston identified a link between late-night eating and sleeping habits, gut health, and metabolic disease, offering new insights into why some individuals with obesity may face risk of inflammation and related health problems.

9 Nov 2026

Animal study raises questions about semaglutide safety during pregnancy

They're the blockbuster drugs transforming weight loss, helping millions of people to shed unwanted kilos.

9 Nov 2026

ACP and OpenEvidence partner to deliver clinical guidance to physicians

The American College of Physicians (ACP), the largest medical specialty organization in the US, and OpenEvidence, the most popular AI for doctors in the United States, announce a collaboration to bring trusted, evidence-based clinical content to physicians at the point of care.

9 Nov 2026

New monoclonal antibody therapy significantly lowers patient triglyceride levels

A phase 2b clinical trial led by Mass General Brigham Heart and Vascular Institute researchers shows that a monoclonal antibody therapy called MAR001 can significantly reduce triglyceride levels within 12 weeks for patients with high triglyceride levels.

9 Nov 2026